Open access · Peer reviewed · No APCs
Review ArticleJournal of Pharmacology and PharmacotherapeuticsVol. 9 | Issue 3 | 2018 | pp. 126–30Open access
Phosphodiesterase 7B1 as Therapeutic Target for Treatment of Cognitive Dysfunctions in Multiple Sclerosis
- 1*,
- 1
- 1 Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Chennai, Tamil Nadu, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Arthi Balsundaram
Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Chennai, Tamil Nadu, India.
Email: rtms86@yahoo.com
Copyright: © 2018 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2018
- Received:
- Jun 11, 2018
- Accepted:
- Oct 12, 2018
How to cite
Balsundaram, A., & Chellathai, D. (2018). Phosphodiesterase 7B1 as Therapeutic Target for Treatment of Cognitive Dysfunctions in Multiple Sclerosis. Journal of Pharmacology and Pharmacotherapeutics, 9(3), 126–30. https://doi.org/10.4103/jpp.JPP_77_18
Abstract
Multiple sclerosis (MS) is an autoimmune, chronic degenerative neuroinflammatory disorder affecting younger age groups of the United States of America and Europe. MS prevalence studies in India have shown that India is no longer a low‑risk zone. Many studies have shown the seriousness of cognitive impairments (CIs) and its types caused in MS. In this review, the pathological basis for CI in various stages of MS was reviewed and revealed to provide a basis for the treatment. Role of phosphodiesterase 7B1 (PDE7B1) inhibitors in treating CI related to MS were also stated in this review. The literature for this review was collected from PubMed and Embase.
Keywords
Subject
Article metadata
| Title | Phosphodiesterase 7B1 as Therapeutic Target for Treatment of Cognitive Dysfunctions in Multiple Sclerosis |
|---|---|
| Authors | Arthi Balsundaram; Darling Chellathai |
| Affiliations | Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Chennai, Tamil Nadu, India. |
| Corresponding author | rtms86@yahoo.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 9, Issue 3 (2018) |
Also in this issue
- Evolving Role of Clinical Pharmacologists in Indian Accredited Hospitalspp. 121–5
- Contribution of Italian Clinical Research for Contrast Media-Induced Nonrenal Adverse Drug Reactions over the Last Three Decades: A Systematic Reviewpp. 131–146
- Development and Implementation of Pharmacology Museum as a Teaching-Learning Tool: A Prospective, Interventional Studypp. 147–152
- Effect of Antihypertensive Pharmacotherapy on Oscillometric Pulse Wave Analysis Parameters in Treated Gujarati Hypertensives: A Cross‑Sectional Studypp. 153–159
- Comorbid Physical and Mental Health Illness of Prescription Opioid Abusers Attending De‑addiction Centers of Sikkim: A Northeastern State of Indiapp. 160–164
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026